Treatment Results

Survival: ?
Toxicity Grade:4
Treatments: Immunotherapy
Country:United States
City/State/Province:Houston, Texas
Hospital:Memorial Hermann Hospital
Date: 12/2002

Patients: This Phase I study involved 29 patients with a variety of different cancers. One patient had mesothelioma.

Treatment: The treatment consisted of injections of recombinant human interleukin-12 (a protein).

Toxicity: Toxicities for all patients included grade 4 lymphopenia, and grade 3 or less nausea, vomiting, fatigue, fever, infection, and abdominal pain.

Results: Of 29 patients, two experienced complete response – the patient with mesothelioma is without progression at two years.

Correspondence: Ralph S. Freedman, MD

Get your free copy of
“Surviving Mesothelioma” Today!